| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6190265 | Cancer Treatment Communications | 2015 | 4 Pages |
Abstract
These results suggest that there may be intratumoral heterogeneity of EGFR mutations, and the therapeutic effect of EGFR-TKIs could be limited only to mutant cells.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Kosuke Mizoguchi, Yoichi Nakamura, Kuniko Abe, Shinnosuke Takemoto, Kohei Motoshima, Daiki Ogawara, Katsumi Nakatomi, Minoru Fukuda, Junya Fukuoka, Shigeru Kohno,